Overview

Precision Care for Major Depressive Disorder

Status:
ENROLLING_BY_INVITATION

Trial end date:
2029-09-01

Target enrollment:

Participant gender:

Summary

This study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.

Phase:

PHASE4

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Methylphenidate
Phenelzine
Pramipexole